Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 2Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 64Peripheral Blood Stem Cell Transplantation 48Etoposide 40Filgrastim 34Rituximab 33Radiotherapy 33fludarabine phosphate 30Busulfan 28Mycophenolic Acid 27Tacrolimus 24Cyclosporine 24Cytarabine 23Antilymphocyte Serum 22Whole-Body Irradiation 21Methotrexate 21Melphalan 21Carmustine 16sargramostim 15Methylprednisolone 15Vincristine 12Prednisone 12Cisplatin 12Doxorubicin 9Dexamethasone 9Cord Blood Stem Cell Transplantation 9Ifosfamide 8Granulocyte Colony-Stimulating Factor 7etoposide phosphate 6Sirolimus 6Carboplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large-Cell, Immunoblastic × Stem Cell Factor × Clear all
NCT00003957 2013-04-17

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Fox Chase Cancer Center

Phase 2 Completed
3 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡